Intellicell Biosciences (United States)

Recent papers from Intellicell Biosciences (United States)

1. Adaptive Laboratory Evolution and Scale-Up of Rhodosporidium toruloides for Commercial Lipid ProductionIndustrial Biotechnology · 2025
2. A PERK-Specific Inhibitor Blocks Metastatic Progression by Limiting Integrated Stress Response–Dependent Survival of Quiescent Cancer CellsClinical Cancer Research · 2023
3. PERK Inhibition by HC-5404 Sensitizes Renal Cell Carcinoma Tumor Models to Antiangiogenic Tyrosine Kinase InhibitorsClinical Cancer Research · 2023
4. Preclinical Evidence of an Allogeneic Dual CD20xCD22 CAR to Target a Broad Spectrum of Patients with B-cell MalignanciesCancer Immunology Research · 2023
5. Activation of Gcn2 by small molecules designed to be inhibitorsJournal of Biological Chemistry · 2023
6. Treatment of Patients with Acute Myeloid Leukemia with the Targeted Alpha-Particle Nanogenerator Actinium-225-LintuzumabClinical Cancer Research · 2022
7. Regenerative Treatments to Enhance Orthopedic Surgical OutcomePM&R · 2015